More topics

Limited coverage drugs – budesonide nebules

Last updated on March 17, 2025

 

Return to Special Authority drug list  

Generic name

 budesonide 

Strength & form

 0.125 mg/mL, 0.25 mg/mL, 0.25 mg/2mL, 0.5 mg/mL, 0.5 mg/2 mL, 1.0 mg/2 mL nebule and solution

Special Authority criteria

Approval period
Person who has cognitive impairment PLUS has had an unsuccessful trial in the use of an inhaler attached to an aerochamber with a mouthpiece

OR

Person who is living independently PLUS either suffers from severe upper extremity disability or lacks fine motor co-ordination to a degree that precludes effective inhaler techniques, even when aided by inhaler-assistance devices

OR

Resident of a long-term care facility PLUS regularly requires the administration of three or more inhaled medications at least three times daily

OR

Person who has difficulty generating adequate inspiratory effort that they are unable to achieve therapeutic benefit from an inhaler with an aerochamber

Indefinite

 

Practitioner exemptions

  • None

Special notes

  • Special Authority is not required for individuals 18 years and younger

Special Authority request form(s)